On Thursday, March 26, the FDA granted authorization for SomrystTM, a prescription-only digital therapeutic for treatment of chronic insomnia in patients aged 22 years or older.
High traditional masculinity (HTM) men are more likely to die by suicide than non-HTM men, but they are less likely to report suicide ideation.
Access to care has improved—especially for low-income and vulnerable populations—which has resulted in better health outcomes.
Although 6 months is the recommended duration for buprenorphine treatment, many patients discontinue within a few weeks or months of treatment.
Researchers tested the effects of ketamine combined with motivational enhancement therapy in adults drinking 5 alcoholic beverages per day.
Recommendations for the use of antipsychotics for the management of behavioral and psychological symptoms of dementia.
A brief synopsis on how to spot major depression in youth.
Climate medicine: What was once on the radar of just a handful of physicians has exploded into awareness, alarm, and sometimes debate and skepticism. No matter how you look at it, psychiatrists are on the front lines.
The immune-brain loop: a world where more and more clinicians boldly go—and thrive—among new discoveries.
News from around the web includes reports on physician burnout, the effects of diet on brain inflammation, written exposure therapy for PTSD, Parkland, psychedelics, benzodiazepines, and social media to gauge mental health.